Analysts expect CV Sciences, Inc. to report revenue of 4.19 M for Q4 23, against a range of 3.77 M to 4.60 M. The most recent reported quarter, Q3 23, came in at 4.09 M, a 0.4% beat against the 4.07 M consensus.
| Metric | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 4.45 M | 4.14 M | 3.75 M | 3.90 M | 4.15 M | 3.97 M | 4.09 M | - | - | - | - | - | - | - | - | |
| High Estimate | 5.00 M | 5.27 M | 4.65 M | 4.64 M | 4.45 M | 4.83 M | 4.20 M | 4.60 M | 7.09 M | 7.52 M | 8.13 M | 8.68 M | 7.92 M | 7.12 M | 8.11 M | |
| Low Estimate | 4.09 M | 4.74 M | 3.92 M | 3.86 M | 3.80 M | 4.13 M | 3.95 M | 3.77 M | 5.94 M | 6.66 M | 7.28 M | 7.93 M | 6.89 M | 5.96 M | 7.24 M | |
| Consensus Estimate | 4.54 M | 5.00 M | 4.28 M | 4.25 M | 4.12 M | 4.48 M | 4.07 M | 4.19 M | 6.51 M | 7.09 M | 7.70 M | 8.31 M | 7.41 M | 6.54 M | 7.68 M |
Analysts expect CV Sciences, Inc. to report earnings per share of -0.01 for Q4 23, against a range of -0.01 to -0.01. The most recent reported quarter, Q3 23, came in at 0.00, a 100.0% beat against the -0.01 consensus.
| Metric | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.02 | -0.03 | -0.01 | -0.01 | 0.04 | -0.01 | 0.00 | - | - | - | - | - | - | - | - | |
| High Estimate | -0.03 | -0.03 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | 0.03 | -0.01 | -0.01 | -0.02 | 0.07 | 0.02 | 0.02 | |
| Low Estimate | -0.03 | -0.03 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | 0.03 | -0.01 | -0.01 | -0.02 | 0.07 | 0.02 | 0.02 | |
| Consensus Estimate | -0.03 | -0.03 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | 0.03 | -0.01 | -0.01 | -0.02 | 0.07 | 0.02 | 0.02 |